HpyloriMAFLDNCT07128147
Detection of Helicopacter Pylori in Patients With Metabolic Associated Fatty Liver Disease
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 8 words Show 4 more changesShow less
- Completed without a posted recruiting period
- Primary completion date changed from estimate of Sep 1, 2026 to Oct 1, 2026
- Study sites: 0 to 1
- Start date changed from estimate of Sep 1, 2026 to Oct 1, 2026
- Notable Start date: Sep 1, 2025 to Sep 1, 2026v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Prevalence of Helicobacter pylori infection in patients with Metabolic Associated Fatty Liver Disease as determined by Urea Breath Test
Timeframe: Baseline (Day 1 of hospital admission)
Prevalence of Helicobacter pylori Infection in Patients with MAFLD
Timeframe: At baseline (hospital admission)
Sites
1 site in 1 country
- Assiut UniversityAsyut, Egypt